Research Study

A Phase 3 Multi-center, Long-term Extension Study Investigating The Efficacy And Safety Of Pf-04965842, With Or Without Topical Medications, Administered To Subjects Aged 12 Years And Older With Moderate To Severe Atopic Dermatitis
Principal Investigator 
Vincent C. Ho

Overview

Body Locations and Systems 
Dermatitis
ClinicalTrials.gov# 
NCT03422822
Status 
Recruiting
Study Start/End 
Oct 11, 2018 to Jul 4, 2021
Locations 
Vancouver General Hospital
Phone 
604-875-5296
Purpose of Study 

The purpose of this study is to learn about the long-term safety and effectiveness of the study drug, PF-04965842 in participants who previously participated in PF-04965842 AD Phase 3 trials.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.